IPR challenge could up the ante of defending drug patents
29 May 2015
Defending patents for drugs and medical devices is part of the stakes of an R&D budget, but the size of that stake could increase significantly if a hedge fund manager wins his inter partes review (IPR) challenge of selected drug patents.
CROs/CMOs Powering Vaccine R&D At Biotechs
29 May 2015
The first is about vaccine shortages and cutting R&D investment. Chacón’s is a positive tale of a growing number of startups and biotechs utilizing CROs/CMOs to create a new R&D industry for innovative vaccines. The antagonists in the first case – placing price ahead of access and free-markets – are the very organizations Chacón lionizes above.
New Push Ties Cost of Drugs to How Well They Work
29 May 2015
Express Scripts Holding Co., a large manager of prescription-drug benefits for U.S. employers and insurers, is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.
Russia gives green light to parallel imports in bid to lower prices
29 May 2015
The Russian government has given its approval to parallel imports, meaning that it will be possible to import some goods for sale in Russia without rights holder permission. The government hopes that this decision will lead to a drop in prices, but experts say that its major consequence will be an increase in counterfeit goods. Moreover, the measure is contrary to the norms of the Eurasian Economic Union, the key integration union on the territory of the former USSR.
Russia makes it easier to skirt imported drug sale norms
28 May 2015
Moscow is opening a gray market to allow imports of drugs intended for sale in other countries to be sold in Russia without the consent of the maker with a trademark for the product. The government hopes the move will lower pharmaceutical costs.
Starting antiretroviral treatment early improves outcomes for HIV-infected individuals
28 May 2015
A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune system health—is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
Singapore moving to meet pharma manufacturing demand for high-quality water
27 May 2015
Singapore, like other Asian countries looking to woo pharmaceutical manufacturers, is moving quickly to meet increasing demand for high-quality water required by strict regulations in the U.S. and European Union.
EU's medicines agency stands by recommendation to suspend drugs studied at GVK India facility
27 May 2015
The European Medicines Agency is standing by its original recommendation made earlier this year to suspend a number of medicines that received European Union clearance based on clinical studies conducted by GVK Biosciences in India.
CBMG says China and U.S. growing quickly closer in biotech space
27 May 2015
Collaboration between biotech companies from the U.S. and China is in a good state of flux as plays from "friends and family" and signs of growing venture capital and Big Pharma licensing deals are in motion at the same time, according to Andrew Chan, senior vice president of corporate business development for China-only Nasdaq-listed biotech, Cellular Biomedicine Group ($CBMG).
Patents: More Important to Biopharmaceutical Sector than Other Industries
26 May 2015
According to Abraham Lincoln, the patent system “secured to the inventor for a limited time exclusive use of his inventions, and thereby added the fuel of interest to the fire of genius in the discovery and productions of new and useful things.”
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024